Clinical Trial Update: RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for ribavirin dose adaptation in chronic hepatitis C. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Chronic Hepatitis C | Phase 3 | Status: UNKNOWN